|
1
|
Gill S, Thomas RR and Goldberg RM: Review
article: colorectal cancer chemotherapy. Aliment Pharmacol Ther.
18:683–692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aggarwal S and Chu E: Current therapies
for advanced colorectal cancer. Oncology. 19:589–595.
2005.PubMed/NCBI
|
|
3
|
André T, Boni C, Mounedji-Boudiat L, et
al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment
for colon cancer. N Engl J Med. 350:2343–2351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meropol NJ and Schulman KA: Cost of cancer
care: issues and implications. J Clin Oncol. 25:180–186. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung KY and Kelsen D: Adjuvant therapy
for stage II colorectal cancer; who and with what? Curr Treat
Options Gastroenterol. 9:272–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aslam MI, Taylor K, Pringle JH and Jameson
JS: microRNAs are novel biomarkers of colorectal cancer. Br J Surg.
96:702–710. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
8
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caldas C and Brenton JD: Sizing up miRNAs
as cancer genes. Nat Med. 11:712–714. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L,
Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and
down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in
chronic lymphocytic leukemia. Proc Natl Acad Sci USA.
99:15524–15529. 2002. View Article : Google Scholar
|
|
11
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M,
Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C,
Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M and
Croce CM: A microRNA signature associated with prognosis and
progression in chronic lymphocytic leukemia. N Engl J Med.
353:1793–1801. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
16
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu
CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Slaby O, Svoboda M, Fabian P, Smerdova T,
Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered
expression of miR21, miR-31, miR-143 and miR-145 is related to
clinicopathological features of colorectal cancer. Oncology.
72:397–402. 2007. View Article : Google Scholar
|
|
18
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I,
Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene
expression deregulation in human breast cancer. Cancer Res.
65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang KH, Miler N, Kheirelseid EA, et al:
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg
Oncol. 37:597–603. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang ZX, Lu BB, Wang H, et al: MicroRNA-21
modulates chemosensitivity of breast cancer cells to doxorubicin by
targeting PTEN. Arch Med Res. 42:281–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ziyan W, Shuhua Y, Xiufang W and Xianoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
27
|
Liu M, Tang Q, Qiu M, et al: miR-21
targets the tumor suppressor RhoB and regulates proliferation,
invasion and apoptosis in colorectal cancer cells. FEBS Lett.
585:2998–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Torres A, Torres K, Paszkowski T, et al:
Highly increased maspin expression corresponds with up-regulation
of miR-21 in colorectal cancer: a preliminary report. Int J Gynecol
Cancer. 21:8–14. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Horiuchi A, Iinuma H, Akahane T, Shimada R
and Watanabe T: Prognostic significance of PDCD4 expression and
association with microRNA-21 in each Dukes’ stage of colorectal
cancer patients. Oncol Rep. 27:1384–1392. 2012.PubMed/NCBI
|
